Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Common Equity: 2023

Historic Common Equity for Sagimet Biosciences (SGMT) over the last 1 years, with Dec 2023 value amounting to $91.1 million.

  • Sagimet Biosciences' Common Equity rose 74.39% to $170.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $170.7 million, marking a year-over-year increase of 74.39%. This contributed to the annual value of $91.1 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Sagimet Biosciences' Common Equity is $91.1 million.
  • In the past 5 years, Sagimet Biosciences' Common Equity registered a high of $91.1 million during FY2023, and its lowest value of $91.1 million during FY2023.
  • Over the past 1 years, Sagimet Biosciences' median Common Equity value was $91.1 million (recorded in 2023), while the average stood at $91.1 million.